Patents by Inventor Gary Rheinheimer

Gary Rheinheimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEVICES AND METHODS FOR MINIMIZING HOOK EFFECT INTEFERENCE IN IMMUNOASSAYS
    Publication number: 20220349877
    Abstract: Methods of minimizing hook effect interference in an immunoassay are disclosed. Also disclosed are reagents, kits, and immunoassay devices that may be utilized in accordance with the method.
    Type: Application
    Filed: July 18, 2022
    Publication date: November 3, 2022
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Chris Zimmerle, Gary Rheinheimer
  • Detection of ascorbic acid in a urine sample
    Patent number: 11262350
    Abstract: Disclosed herein are methods of detecting ascorbic acid in a urine sample from a subject, including contacting at least a portion of the urine sample with a test strip including a reagent pad and detecting whether ascorbic acid is present in the urine sample by measuring an intensity of color on the reagent pad, wherein a reduction in the intensity of color on the reagent pad indicates the presence of ascorbic acid.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: March 1, 2022
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Chris Zimmerle, Gary Rheinheimer
  • DETECTION OF ASCORBIC ACID IN A URINE SAMPLE
    Publication number: 20210311026
    Abstract: Disclosed herein are methods of detecting ascorbic acid in a urine sample from a subject. The methods comprise contacting at least a portion of the urine sample with a test strip comprising a reagent pad and detecting whether ascorbic acid is present in the urine sample. The detecting comprises measuring an intensity of color on the reagent pad, wherein a reduction in the intensity of color on the reagent pad indicates the presence of ascorbic acid.
    Type: Application
    Filed: October 27, 2017
    Publication date: October 7, 2021
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Chris Zimmerle, Gary Rheinheimer
  • DEVICES AND METHODS FOR MINIMIZING HOOK EFFECT INTEFERENCE IN IMMUNOASSAYS
    Publication number: 20200064339
    Abstract: Methods of minimizing hook effect interference in an immunoassay are disclosed. Also disclosed are reagents, kits, and immunoassay devices that may be utilized in accordance with the method.
    Type: Application
    Filed: May 4, 2018
    Publication date: February 27, 2020
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Chris Zimmerle, Gary Rheinheimer
  • Generic method for latex agglutination assays
    Patent number: 7935539
    Abstract: An improved agglutination immunoassay is characterized by reacting a sample fluid which may contain an analyte with a generic antibody conjugated to latex particles and then adding an antibody specific to the analyte to be determined. Agglutination resulting from adding the antibody specific to the analyte is measured and correlated with the amount of analyte in the sample.
    Type: Grant
    Filed: February 14, 2003
    Date of Patent: May 3, 2011
    Assignee: Siemens Healthcare Diagnostics, Inc.
    Inventors: David Brock, Jim Mattler, Gary Rheinheimer
  • Verification device and method for optical inspection machine
    Publication number: 20060257284
    Abstract: An apparatus for verifying proper operation of an optical inspection machine, including a row of colored segments that simulate reagent pads containing known types of analytes at known concentrations positioned so that the row of colored segments can be illuminated by the readhead of the optical inspection machine. If the optical inspection machine provides results that correspond to the known types and concentrations of analytes, then the machine is operating properly.
    Type: Application
    Filed: June 3, 2004
    Publication date: November 16, 2006
    Inventors: Gary Rheinheimer, Chris Zimmerle, David Brock, Gary Krauth
  • Generic method for latex agglutination assays
    Publication number: 20040161863
    Abstract: Am improved agglutination immunoassay is characterized by reacting a sample fluid which may contain an analyte with a generic antibody conjugated to latex particles and then adding an antibody specific to the analyte to be determined. Agglutination resulting from adding the antibody specific to the analyte is measured and correlated with the amount of analyte in the sample.
    Type: Application
    Filed: February 14, 2003
    Publication date: August 19, 2004
    Inventors: David Brock, Jim Mattler, Gary Rheinheimer